graphic
News > Companies
Merck stock breathing easy
February 23, 1998: 12:22 p.m. ET

Shares rise after FDA approves marketing of one-a-day asthma pill
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Shares of Merck & Co. Inc. were higher Monday after the drug giant said the Food and Drug Administration has cleared for marketing its new once-a-day asthma pill, Singulair.
     The non-steroid Singulair is in a class of drugs known as leukotriene blockers and is set to hit drugstore shelves next month.
     Merck shares (MRK) got an injection from the announcement, adding 3 7/8 to 128 9/16 in midday trading Monday.
     The announcement is a further boost to Merck stock following recent acquisition fever among drug stocks. Its share price has risen roughly 50 percent since last November.
     The release of the new preventative therapy comes as the incidence of asthma is growing. Experts are divided over the reasons for the increasing incidence.
     Currently, an estimated 15 million Americans -- 5 million of them children -- suffer from the respiratory disease.
     Whitehouse Station, N.J.-based Merck is expected to market a reduced-dose, cherry-flavored version of the pill for children over six years of age.
     "There are a lot of asthma pills out there, but this may be the best one yet," said Hambrecht & Quist analyst Alex Zisson. "It has a benign side-effect profile and high efficiency."
     But Singular, as a preventative therapy, won't mean an end to that ever-present playground buddy -- the asthma medicine inhaler -- Zisson said.
     The new drug's accomplishment, he said, is that it is taken once a day, while others must be taken more often.
     Meanwhile, rivals Glaxo Wellcome Inc. and Astra AB may soon receive U.S. approval for their dry-powder asthma inhalers already available in Europe. And new asthma medicine delivery devices are on the way as well.
     The asthma drug market accounted for about $2 billion in sales in 1997.Back to top

  RELATED STORIES

Drugs have few side effects - Jan. 27, 1998

  RELATED SITES

Merck


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic


Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.